Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Adam Fein, PhD

Adam Fein, PhD, Founder & President, Pembroke Consulting Inc Founder & President
Pembroke Consulting Inc
Member of the Healthcare Council

Adam Fein, PhD, is the Founder and President of Pembroke Consulting, Inc., a Philadelphia-based management advisory and business research firm. Dr. Fein is one of the country’s foremost experts on pharmacy economics and the pharmaceutical supply chain. He provides strategic advisory services to a diverse mix of clients, including pharmaceutical manufacturers, pharmacy benefit managers, supply chain technology companies, law firms, health care providers, trade associations, and institutional investors. Dr. Fein has published over 100 academic and industry articles, authored or edited nine books, and currently writes the popular blog DrugChannels.net. He is frequently sought by the media for his industry expertise and has been quoted in many leading national publications. Dr. Fein serves as the first Fellow of the NAW Institute for Distribution Excellence and is on the Advisory Boards of Supply Chain Equity Partners, Secure Symbology, IntegriChain, and Pharmaceutical Commerce magazine. (This is me - Update Profile)


Employment History
1997 - present Founder & President
Pembroke Consulting Inc

GLG NewsSM Analyses by Adam Fein, PhD(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Progress on Federal Pedigree Will be Slow | 09-05-2008
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

Representatives Steve Buyer (R-IN), Gene Green (D-TX), Jim Matheson (D-UT), and Mike Rogers (R-MI) co-sponsored H.R. 5839 Safeguarding America’s Pharmaceuticals Act of 2008. H.R. 5839 was going to be incorporated into other related FDA legislation, but intense behind-the scenes lobbying by the pharmacy...

CA E-Pedigree Delayed to 2015 | 09-04-2008
Analysis of: Bill to track medicines is praised | www.signonsandiego.com
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

Implementation of California’s e-pedigree law has (probably) been pushed back to 2015. The widespread industry support for the bill makes me believe that the 2015 date might actually stick. The more realistic timeline should encourage pharmaceutical manufacturers to get serious about mass serialization...

California Debates a Tougher Drug Supply Chain Law | 07-09-2008
Analysis of: Time To Protect The Pharmaceutical Supply Chain | www.capitolweekly.net
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

State Senator Mark Ridley-Thomas’ editorial argues California needs its own pharmaceutical supply chain security laws because the Federal government has failed to implement the Prescription Drug Marketing Act (PDMA). However, it does not necessarily follow that every individual state pharmacy board...

A Faulty Track-and-Trace Cost Model for Pharmacies | 07-02-2008
Author: Adam Fein, PhD, Founder & President, Pembroke Consulting Inc

A new report from Accenture attempts to assess the financial costs of implementing a serialized track-and-trace system for the U.S. pharmacy supply chain. But even if we assume that Accenture did a credible and impartial job building their pharmacy cost models, the estimates in this report reflect an...

View All GLG News SM Analyses by Adam Fein, PhD

GLG InstituteSM Seminars with Adam Fein, PhD(?)

 
Adam Fein, PhD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Adam Fein, PhD









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-07T01:45:17.680